Compositions and methods for modifying properties of biologically active polypeptides

Details for Australian Patent Application No. 2008287340 (hide)

Owner Amunix, Inc.

Inventors Yin, Yong; Schellenberger, Volker; Bogin, Oren; Wang, Chia-Wei; Geething, Nathan C.; Stemmer, Willem P.

Agent Pizzeys

Pub. Number AU-A-2008287340

PCT Pub. Number WO2009/023270

Priority 60/981,073 18.10.07 US; 60/956,109 15.08.07 US; 60/986,569 08.11.07 US

Filing date 15 August 2008

Wipo publication date 19 February 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

18 February 2010 PCT application entered the National Phase

  PCT publication WO2009/023270 Priority application(s): WO2009/023270

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008287341-Kappa-carrageenase and kappacarrageenase-containing compositions

2008287339-4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5h-pyrimido [4, 5-B[1, 4] diazepin2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases PLK1 to PLK4 for the treatment of proliferative diseases